Trial
NCT00368602
Beta Blocker for Chronic Wound Healing
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
—
Condition
Ulcer
Intervention
Timoptic
Why stopped
Lack of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-07